Cancer Research Cancer Genome no Abstract
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tillman, D. M.
Right arrow Articles by Houghton, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tillman, D. M.
Right arrow Articles by Houghton, J. A.
[Cancer Research 63, 5118-5125, August 15, 2003]
© 2003 American Association for Cancer Research


Regular Articles

Rottlerin Sensitizes Colon Carcinoma Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis via Uncoupling of the Mitochondria Independent of Protein Kinase C1

David M. Tillman, Kamel Izeradjene, Kinga Szekely Szucs, Leslie Douglas and Janet A. Houghton2

Division of Molecular Therapeutics, Department of Hematology-Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105

Signaling pathways involved in survival responses may attenuate the apoptotic response to the cytotoxic tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in human colon carcinomas. In six lines examined, three were sensitive (GC3/c1, VRC5/c1, HCT116), HT29 demonstrated intermediate sensitivity, and RKO and HCT8 were resistant to TRAIL-induced apoptosis. Calphostin c [an inhibitor of classic and novel isoforms of protein kinase C (PKC)] sensitized five of six cell lines to TRAIL, whereas Go6976, (inhibitor of classic PKC isoforms), did not influence TRAIL sensitivity. Rottlerin, an inhibitor of novel isoforms of PKC, specifically PKC{delta}, sensitized five of six cell lines to TRAIL-induced apoptosis, suggesting that PKC{delta} may be involved in the mechanism of TRAIL resistance. Transfection of HCT116 with a proapoptotic cleaved fragment of PKC{delta} or an antiapoptotic full-length PKC{delta} did not influence the sensitivity of HCT116 to TRAIL. Furthermore, the incubation of HCT116 or RKO with phorbol myristate acetate for 16 h, which down-regulated the expression of novel PKC isoforms, also did not influence sensitivity to TRAIL either in the absence or presence of rottlerin. However, after 15-min incubation with rottlerin, mitochondrial membrane potential ({Delta}{psi}m) was dramatically reduced in RKO cells, and, in cells subsequently treated with TRAIL, rapid apoptosis was evident within 8 h. Calphostin c, but not Go6976, also caused a decrease in {Delta}{psi}m. In RKO, rottlerin induced the release of cytochrome c, HtrA2/Omi, Smac/DIABLO, and AIF from the mitochondria, potentiated in combination with TRAIL, with concomitant caspase activation and down-regulation of XIAP. In HT29, the release of proapoptotic factors was demonstrated only when rottlerin and TRAIL were combined, and Bcl-2 overexpression inhibited this release and the induction of apoptosis. TRAIL-induced apoptosis was not influenced by rottlerin or Bcl-2 overexpression in type I (GC3/c1) cells. Data suggest that rottlerin affects mitochondrial function independent of PKC{delta}, thereby sensitizing cells to TRAIL, and that mitochondria constitute an important target in overcoming inherent resistance to TRAIL in colon carcinomas.




This article has been cited by other articles:


Home page
DiabetesHome page
Y.-H. Kim, Y.-S. Kim, C.-H. Park, I.-Y. Chung, J.-M. Yoo, J.-G. Kim, B.-J. Lee, S.-S. Kang, G.-J. Cho, and W.-S. Choi
Protein Kinase C-{delta} Mediates Neuronal Apoptosis in the Retinas of Diabetic Rats via the Akt Signaling Pathway
Diabetes, August 1, 2008; 57(8): 2181 - 2190.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Basu, B. Adkins, and C. Basu
Down-regulation of Caspase-2 by Rottlerin via Protein Kinase C-{delta}-Independent Pathway
Cancer Res., April 15, 2008; 68(8): 2795 - 2802.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
P. Shivshankar, L. Lei, J. Wang, and G. Zhong
Rottlerin Inhibits Chlamydial Intracellular Growth and Blocks Chlamydial Acquisition of Sphingolipids from Host Cells
Appl. Envir. Microbiol., February 15, 2008; 74(4): 1243 - 1249.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. R. Klinger, J. D. Murray, B. Casserly, D. F. Alvarez, J. A. King, S. S. An, G. Choudhary, A. N. Owusu-Sarfo, R. Warburton, and E. O. Harrington
Rottlerin causes pulmonary edema in vivo: a possible role for PKC{delta}
J Appl Physiol, December 1, 2007; 103(6): 2084 - 2094.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
R.-Y. Su, Y. Chao, T.-Y. Chen, D.-Y. Huang, and W.-W. Lin
5-Aminoimidazole-4-carboxamide riboside sensitizes TRAIL- and TNF{alpha}-induced cytotoxicity in colon cancer cells through AMP-activated protein kinase signaling
Mol. Cancer Ther., May 1, 2007; 6(5): 1562 - 1571.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. C. Phillips, S. Martin, B. T. Doyle, and J. A. Houghton
Sphingosine-Induced Apoptosis in Rhabdomyosarcoma Cell Lines Is Dependent on Pre-Mitochondrial Bax Activation and Post-Mitochondrial Caspases
Cancer Res., January 15, 2007; 67(2): 756 - 764.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. P. Jane, D. R. Premkumar, and I. F. Pollack
Coadministration of Sorafenib with Rottlerin Potently Inhibits Cell Proliferation and Migration in Human Malignant Glioma Cells
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1070 - 1080.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Martin, D. C. Phillips, K. Szekely-Szucs, L. Elghazi, F. Desmots, and J. A. Houghton
Cyclooxygenase-2 Inhibition Sensitizes Human Colon Carcinoma Cells to TRAIL-Induced Apoptosis through Clustering of DR5 and Concentrating Death-Inducing Signaling Complex Components into Ceramide-Enriched Caveolae
Cancer Res., December 15, 2005; 65(24): 11447 - 11458.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Kim, J. J. Song, J. Y. An, Y. T. Kwon, and Y. J. Lee
Pretreatment of Acetylsalicylic Acid Promotes Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis by Down-regulating BCL-2 Gene Expression
J. Biol. Chem., December 9, 2005; 280(49): 41047 - 41056.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Gonzalez-Guerrico and M. G. Kazanietz
Phorbol Ester-induced Apoptosis in Prostate Cancer Cells via Autocrine Activation of the Extrinsic Apoptotic Cascade: A KEY ROLE FOR PROTEIN KINASE C{delta}
J. Biol. Chem., November 25, 2005; 280(47): 38982 - 38991.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. I. Zakharov, J. P. Morrow, G. Liu, L. Yang, and S. O. Marx
Activation of the BK (SLO1) Potassium Channel by Mallotoxin
J. Biol. Chem., September 2, 2005; 280(35): 30882 - 30887.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Izeradjene, L. Douglas, D. M. Tillman, A. B. Delaney, and J. A. Houghton
Reactive Oxygen Species Regulate Caspase Activation in Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Resistant Human Colon Carcinoma Cell Lines
Cancer Res., August 15, 2005; 65(16): 7436 - 7445.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. K. Basu, M. Kovarova, A. Garza, S. Kubota, T. Saha, P. S. Mitra, R. Banerjee, J. Rivera, and I. S. Owens
Phosphorylation of a UDP-glucuronosyltransferase regulates substrate specificity
PNAS, May 3, 2005; 102(18): 6285 - 6290.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-H. Woo, J.-H. Lim, and J.-H. Kim
Lipopolysaccharide Induces Matrix Metalloproteinase-9 Expression via a Mitochondrial Reactive Oxygen Species-p38 Kinase-Activator Protein-1 Pathway in Raw 264.7 Cells
J. Immunol., December 1, 2004; 173(11): 6973 - 6980.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Izeradjene, L. Douglas, A. Delaney, and J. A. Houghton
Influence of Casein Kinase II in Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Human Rhabdomyosarcoma Cells
Clin. Cancer Res., October 1, 2004; 10(19): 6650 - 6660.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Deutsch, A. Cohen, G. Kazimirsky, S. Dovrat, H. Rubinfeld, C. Brodie, and R. Sarid
Role of Protein Kinase C {delta} in Reactivation of Kaposi's Sarcoma-Associated Herpesvirus
J. Virol., September 15, 2004; 78(18): 10187 - 10192.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. I. Geller, K. Szekely-Szucs, I. Petak, B. Doyle, and J. A. Houghton
P21Cip1 Is a Critical Mediator of the Cytotoxic Action of Thymidylate Synthase Inhibitors in Colorectal Carcinoma Cells
Cancer Res., September 1, 2004; 64(17): 6296 - 6303.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Sonnemann, V. Gekeler, A. Sagrauske, C. Muller, H.-P. Hofmann, and J. F. Beck
Down-regulation of protein kinase C{eta} potentiates the cytotoxic effects of exogenous tumor necrosis factor-related apoptosis-inducing ligand in PC-3 prostate cancer cells
Mol. Cancer Ther., July 1, 2004; 3(7): 773 - 781.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. N. Demidenko and M. V. Blagosklonny
Flavopiridol Induces p53 via Initial Inhibition of Mdm2 and p21 and, Independently of p53, Sensitizes Apoptosis-Reluctant Cells to Tumor Necrosis Factor
Cancer Res., May 15, 2004; 64(10): 3653 - 3660.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.